Hundreds of websites have been hawking fake Ozempic and other weight loss drugs. More may be comingByBruce GilUpdatedApril 15, 2024
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine salesByBruce GilUpdatedApril 15, 2024
The weight loss drug Ozempic is not linked to suicidal thoughts, regulators sayByBruce GilUpdatedApril 12, 2024
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round upByBruce GilPublishedApril 12, 2024
The number of active drug shortages reached a record high this year, report saysByBruce GilPublishedApril 11, 2024
Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummetedByBruce GilPublishedApril 11, 2024
Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trialsByBruce GilUpdatedApril 11, 2024
Biotech giant Vertex bought Alpine in a cash deal of $4.9 billionByFrancisco VelasquezPublishedApril 10, 2024
Pfizer wants the first FDA approval ever for an RSV vaccine for young adultsByBruce GilPublishedApril 9, 2024
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundupByBruce GilPublishedMarch 29, 2024
CVS, Kaiser, and Elevance are among the first Medicare plans to start covering WegovyByBruce GilPublishedMarch 28, 2024
